Internal Medicine, Gastroenterology · Murrieta, CA
NPI
1588869382
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
25495 Medical Center Dr Ste 306
Murrieta, CA, 92562
Phone (951) 304-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
942 services
Medicare patients, 2024
317
Average age 72
Drug cost, 2024
$1.4M
2,025 prescriptions
Company payments, 2025
$2,352
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naishadh N Raghuwanshi was code 99232 (hospital e&m - subsequent), 157 times for 65 patients. In total Naishadh N Raghuwanshi billed 942 services in 32 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 157 | 65 | $62.67 | $9,839 |
| 99204 Office E&M - New | Office | 135 | 135 | $107.99 | $15K |
| 99214 Office E&M - Established | Facility | 132 | 129 | $73.17 | $9,658 |
| 43239 Upper GI Endoscopy | Facility | 95 | 93 | $74.83 | $7,109 |
| 99222 Hospital E&M - Initial | Facility | 90 | 83 | $103.83 | $9,344 |
| 99214 Office E&M - Established | Office | 89 | 75 | $91.52 | $8,145 |
| 45380 Lower GI Endoscopy - Other | Facility | 61 | 60 | $124.97 | $7,623 |
| 45385 Colonoscopy - Lesion Removal | Facility | 39 | 39 | $194.43 | $7,583 |
| 45378 Lower GI Endoscopy - Other | Facility | 33 | 33 | $138.43 | $4,568 |
| 99205 Office E&M - New | Office | 15 | 15 | $153.62 | $2,304 |
| 99215 Office E&M - Established | Office | 14 | 13 | $130.32 | $1,824 |
By year: 2022 $79K for 881 services; 2023 $77K for 776 services; 2024 $90K for 942 services.
Medicare prescription drug claims, 2024
In 2024, the drug Naishadh N Raghuwanshi prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 454 prescriptions and refills. In total Naishadh N Raghuwanshi wrote 2,025 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 454 | 454 | 445 | $26K |
| Omeprazole Generic | 364 | 611 | 118 | $3,057 |
| Linzess Linaclotide | 140 | 173 | 47 | $90K |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 129 | 129 | 126 | $15K |
| Pantoprazole Sodium Generic | 124 | 252 | 42 | $1,140 |
| Famotidine Generic | 113 | 192 | 30 | $1,183 |
| Dicyclomine Hcl Generic | 63 | 66 | 34 | $462 |
| Mesalamine Generic | 38 | 66 | 12 | $4,418 |
| Creon Lipase/Protease/Amylase | 34 | 38 | 11 | $114K |
| Sucralfate Generic | 33 | 51 | 19 | $1,158 |
| Lubiprostone Generic | 28 | 44 | Under 11 | $2,287 |
| Lactulose Generic | 27 | 31 | Under 11 | $314 |
| Trulance Plecanatide | 27 | 32 | Under 11 | $18K |
| Clarithromycin Generic | 24 | 24 | 22 | $632 |
| Amoxicillin Generic | 23 | 23 | 22 | $93.62 |
Brand drugs: 587 claims; generic drugs: 1,438 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naishadh N Raghuwanshi $2,352 ($2,352 in general payments such as food, travel and fees) from 19 companies. The largest payer was Madrigal Pharmaceuticals with $609.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 12 | $609 |
| Abbvie Inc. ABBV | 38 | $569 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $198 |
| Celltrion USA Inc. 068270.KS | 8 | $174 |
| Lilly USA, LLC LLY | 5 | $133 |
| Intercept Pharmaceuticals, Inc. | 6 | $104 |
| Janssen Biotech, Inc. JNJ | 4 | $94.5 |
| Vivus LLC | 4 | $82.75 |
| Gilead Sciences, Inc. GILD | 3 | $60.42 |
| Ardelyx, Inc. ARDX | 2 | $59.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.